Genovate Biotechnology Co., Ltd.

TPEX:4130 Stock Report

Market Cap: NT$2.5b

Genovate Biotechnology Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chia-Chen Chu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure1.5yrs

Recent management updates

Recent updates

Reflecting on Genovate Biotechnology's (GTSM:4130) Share Price Returns Over The Last Five Years

Mar 09
Reflecting on Genovate Biotechnology's (GTSM:4130) Share Price Returns Over The Last Five Years

Does It Make Sense To Buy Genovate Biotechnology Co., Ltd. (GTSM:4130) For Its Yield?

Feb 10
Does It Make Sense To Buy Genovate Biotechnology Co., Ltd. (GTSM:4130) For Its Yield?

Genovate Biotechnology Co., Ltd.'s (GTSM:4130) Dismal Stock Performance Reflects Weak Fundamentals

Jan 04
Genovate Biotechnology Co., Ltd.'s (GTSM:4130) Dismal Stock Performance Reflects Weak Fundamentals

How Much Did Genovate Biotechnology's(GTSM:4130) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 08
How Much Did Genovate Biotechnology's(GTSM:4130) Shareholders Earn From Share Price Movements Over The Last Five Years?

CEO

Chia-Chen Chu

no data

Tenure

Chia-Chen Chu is General Manager & Director of Genovate Biotechnology Co., Ltd.


Board Members

NamePositionTenureCompensationOwnership
Zheng Chen
Chairman & CSOno datano data0.20%
NT$ 5.0m
Chia-Chen Chu
General Manager & Directorno datano datano data
Qi Neng Zhang
Supervisorno datano datano data
Li Hui Zhu
Supervisor18.3yrsno datano data
Ke Yi Liu
Independent Directorno datano datano data
Chin-Ming Chang
Independent Director1.5yrsno datano data
Chi-Ying Huang
Representative Director1.5yrsno datano data
Shih-Jen Lee
Independent Directorno datano datano data
Hsiu-hui Chen
Representative Director1.5yrsno datano data
Lai-Shou Su
Independent Directorless than a yearno datano data

1.5yrs

Average Tenure

Experienced Board: 4130's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.